Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study. Cai M, Choi T, Xie Y, Al-Aly Z, et al. BMJ 2026;392:e086886.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cai M, Choi T, Xie Y, Al-Aly Z, et al. Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study. BMJ 2026;392:e086886.
PMID: 41781010